4. The following problem requires present value information:
Biotech sold a patent on a new blood analyzer to Pharma. The sales agreement which was signed on
January 1, 2009 requires Pharma to pay Biotech $1 million immediately. In addition, Pharma is required
to pay $700,000 each December 31 for 20 years starting with December 31, 2009. Pharma and Biotech
judge that a 10 percent is an appropriate interest rate for this arrangement.
Compute the present value of the receivable on Biotech’s books on January 1, 2009
immediately after receiving the $1 million down payment.
Compute the present value of the receivable on Biotech’s books on December 31, 2009.
Compute the present value of the receivable on Biotech’s books on December 31, 2010.
5. Jurgen Company’s income tax return shows income taxes for 2010 of $75,000 (that is, $75,000 is owed
for 2010). For financial reporting, the firm reports deferred tax assets of $67,900 at the beginning of
2010 and $63,600 at the end of 2010. It reports deferred tax liabilities of $53,600 at the beginning of
2010 and $59,400 at the end of 2010.
Required:
a. Compute the amount of income tax expense for 2010.
b. Assume for this part that the firm’s deferred tax assets are as stated above for 2010 but that its deferred
tax liabilities were $83,500 at the beginning of 2010 and $72,100
at the end of 2010. Compute the amount of income tax expense for 2010.
c. Explain contextually why income tax expense is higher than taxes owed in Part a and lower than taxes
owed in Part b.